Market Size in 2023 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 4,583.90 Million | USD 10,897.40 Million | CAGR at 10.10% | 2023 |
According to the report published by Zion Market Research, the global HIV/AIDS Diagnostics Market size was valued at USD 4,583.90 Million in 2023 and is predicted to reach USD 10,897.40 Million by the end of 2032. The market is expected to grow with a CAGR of 10.10% during the forecast period. The report analyzes the global HIV/AIDS Diagnostics Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the HIV/AIDS Diagnostics Market industry.
HIV/AIDS diagnostics are used to examine the presence of the human immune-deficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in saliva, serum or urine. HIV/AIDS diagnostics helps to detect antibodies, RNA or antigens. Blood tests are the most regular way to make a diagnosis of HIV. HIV is most commonly diagnosed by doing a urine test and blood test.
According to WHO research, until now around 75 million people are infected with human immune-deficiency virus (HIV) and around 30 million people died of HIV disease. With the growing mortality rate, the government and non-government organizations are taking major initiatives to increase the awareness among the people regarding HIV/AIDS and are also providing economic help for diagnostic management thus driving the HIV/AIDS diagnostics market. With the progression of technology, novel diagnostic products are easily accessible in the market which needs the least amount of technical skills that fasten the diagnosis process.
In developing countries such as China and India where a growing population is becoming a major concern, increasing awareness about HIV, and up-coming economies will be the major driving factor for HIV/AIDS diagnostics market. Rise in incidence of HIV infection, knowledge about HIV/AIDs diagnosis and treatment, growing research & development for treatment, early diagnosis, and prevention are the other major factors boosting the HIV/AIDS diagnostics market.
The HIV/AIDS diagnostics market is divided based on the product type, test type, and end-user.
Based on the product type, the HIV/AIDS diagnostics market has been classified into instruments, kits and reagents, and others.
Based on the test type, the HIV/AIDS diagnostics market is categorized into nucleic acid tests, rapid tests (POC), ELISA, and others.
Based on the end users, the global HIV/AIDS diagnostics market is divided into private diagnostics laboratories, hospitals, research institutes & others, and academic.
Report Attributes | Report Details |
---|---|
Report Name | HIV/AIDS Diagnostics Market Research Report |
Market Size in 2023 | USD 4,583.90 Million |
Market Forecast in 2032 | USD 10,897.40 Million |
Growth Rate | CAGR of 10.10% |
Number of Pages | 196 |
Key Companies Covered | Hologic, Inc., Alere, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., OraSure Technologies, Inc., Siemens Healthineers, and Chembio Diagnostic Systems among others |
Segments Covered | By Product type, By Test type, By End-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Regionally, the global HIV/AIDS diagnostics market is classified into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. North America anticipates dominating the HIV/AIDS diagnostics market with the highest market share. In the future years, the region is anticipated to hold on to its leading position by growing at a tremendous rate in the years to come. This development is due to the growing awareness about the various HIV/AIDS diagnosis, test, several initiatives taken by the government to prevent HIV, and expansion in research and development facilities. It is expected that North America will be followed by Europe and the Asia Pacific. It is also anticipated that in the coming years the Middle East will witness sluggish growth rate due to lack of awareness.
Some of the major companies in the global HIV/AIDS diagnostics market are:
By Product type
By Test type
By End-user
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed